Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2024 Aug 21;11(5):e200310. doi: 10.1212/NXI.0000000000200310

Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study

PMCID: PMC11340933  PMID: 39167738

In the Research Article “Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study” by Blant et al.,1 the study groups in the byline should be listed as the “CORPUS and Italian PML study groups.” The article has been replaced by a corrected version. The authors regret the error.

Reference

  • 1.Blant JC, De Rossi NN, Gold R, et al. Presentation and outcome in S1P-RM and natalizumab-associated progressive multifocal leukoencephalopathy: a multicenter cohort study. Neurol Neuroimmunol Neuroinflamm. 2024;11(5):e200281. doi: 10.1212/NXI.0000000000200281 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES